DocGo (DCGO) Competitors $4.17 -0.10 (-2.34%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DCGO vs. NHC, VRDN, AHCO, CDNA, AGL, PNTG, AVAH, CSTL, GRAL, and FLGTShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include National HealthCare (NHC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), agilon health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Grail (GRAL), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. DocGo vs. National HealthCare Viridian Therapeutics AdaptHealth CareDx agilon health The Pennant Group Aveanna Healthcare Castle Biosciences Grail Fulgent Genetics DocGo (NASDAQ:DCGO) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment. Does the media refer more to DCGO or NHC? In the previous week, DocGo had 3 more articles in the media than National HealthCare. MarketBeat recorded 3 mentions for DocGo and 0 mentions for National HealthCare. DocGo's average media sentiment score of 0.98 beat National HealthCare's score of -0.59 indicating that DocGo is being referred to more favorably in the media. Company Overall Sentiment DocGo Positive National HealthCare Negative Do institutionals & insiders have more ownership in DCGO or NHC? 56.4% of DocGo shares are held by institutional investors. Comparatively, 56.4% of National HealthCare shares are held by institutional investors. 2.7% of DocGo shares are held by company insiders. Comparatively, 13.8% of National HealthCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is DCGO or NHC more profitable? National HealthCare has a net margin of 10.03% compared to DocGo's net margin of 4.35%. DocGo's return on equity of 8.90% beat National HealthCare's return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% National HealthCare 10.03%6.87%4.68% Do analysts recommend DCGO or NHC? DocGo presently has a consensus target price of $6.10, indicating a potential upside of 46.28%. Given DocGo's stronger consensus rating and higher possible upside, equities research analysts plainly believe DocGo is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, DCGO or NHC? DocGo has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Does the MarketBeat Community favor DCGO or NHC? DocGo received 43 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 75.00% of users gave DocGo an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4575.00% Underperform Votes1525.00% National HealthCareOutperform Votes2100.00% Underperform VotesNo Votes Which has better earnings and valuation, DCGO or NHC? National HealthCare has higher revenue and earnings than DocGo. National HealthCare is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$624.29M0.68$6.86M$0.2814.89National HealthCare$1.14B1.33$66.80M$7.9812.36 SummaryDocGo beats National HealthCare on 10 of the 17 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$416.37M$1.05B$5.24B$8.95BDividend YieldN/A2.02%5.13%4.04%P/E Ratio14.8930.9889.5417.34Price / Sales0.683.931,255.2478.66Price / Cash19.1623.8143.8235.97Price / Book1.422.845.324.79Net Income$6.86M-$3.80M$122.69M$225.00M7 Day Performance2.21%-0.06%-0.16%1.52%1 Month Performance-2.57%2.20%3.75%4.68%1 Year Performance25.23%175.29%27.41%20.89% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.2254 of 5 stars$4.17-2.3%$6.10+46.3%+28.3%$416.37M$624.29M14.894,164Analyst ForecastNews CoverageNHCNational HealthCareN/A$97.01+0.2%N/AN/A$1.50B$1.23B12.1612,400VRDNViridian Therapeutics2.0864 of 5 stars$17.77-2.4%$35.70+100.9%-18.7%$1.41B$302,000.00-4.1250Short Interest ↑Positive NewsAHCOAdaptHealth3.6383 of 5 stars$10.33+1.9%$12.40+20.0%+58.4%$1.39B$3.26B-6.2610,700Short Interest ↓Positive NewsCDNACareDx3.7123 of 5 stars$25.07+6.1%$29.60+18.1%+115.7%$1.34B$312.78M-9.29740Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageHigh Trading VolumeAGLagilon health3.2361 of 5 stars$2.89+18.9%$3.98+37.8%-57.1%$1.19B$5.59B-3.07650Analyst ForecastNews CoveragePNTGThe Pennant Group4.1737 of 5 stars$26.23+1.6%$36.00+37.2%+75.6%$900.95M$652.30M38.575,791AVAHAveanna Healthcare0.7557 of 5 stars$4.44-1.6%$4.51+1.6%+101.3%$857.92M$1.98B-13.0633,500News CoverageCSTLCastle Biosciences3.4269 of 5 stars$26.15-13.6%$40.29+54.1%+29.7%$732.38M$311.88M130.76540High Trading VolumeGRALGrail0.287 of 5 stars$18.57+4.7%$16.00-13.8%N/A$623.97M$117.67M0.001,360Short Interest ↑News CoverageFLGTFulgent Genetics4.1689 of 5 stars$17.94-2.0%$22.00+22.6%-34.5%$548.73M$277.76M-3.251,010Positive News Related Companies and Tools Related Companies NHC Alternatives VRDN Alternatives AHCO Alternatives CDNA Alternatives AGL Alternatives PNTG Alternatives AVAH Alternatives CSTL Alternatives GRAL Alternatives FLGT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCGO) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
